We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.
- Authors
Chan, J M; Stampfer, M J; Giovannucci, E; Gann, P H; Ma, J; Wilkinson, P; Hennekens, C H; Pollak, M
- Abstract
Insulin-like growth factor-I (IGF-I) is a mitogen for prostate epithelial cells. To investigate associations between plasma IGF levels and prostate cancer risk, a nested case-control study within the Physicians' Health Study was conducted on prospectively collected plasma from 152 cases and 152 controls. A strong positive association was observed between IGF-I levels and prostate cancer risk. Men in the highest quartile of IGF-I levels had a relative risk of 4.3 (95 percent confidence interval 1.8 to 10.6) compared with men in the lowest quartile. This association was independent of baseline prostate-specific antigen levels. Identification of plasma IGF-I as a predictor of prostate cancer risk may have implications for risk reduction and treatment.
- Publication
Science (New York, N.Y.), 1998, Vol 279, Issue 5350, p563
- ISSN
0036-8075
- Publication type
Journal Article
- DOI
10.1126/science.279.5350.563